在性结肠炎的微环境中,炎症的分子活性和上皮-介质细胞过渡
Yu Kyung Jun1, Nayoung Kim1,2, Hyuk Yoon1
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Gut and liver
|February 22, 2024
概括
性结肠炎 (UC) 在炎症和非炎症区域的基因表达增加,表明炎症和组织重塑. 与治愈的患者相比,未治愈的UC患者表现出较高的关键炎症和重塑标志物的表达.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 炎症研究 炎症研究
背景情况:
- 性结肠炎 (UC) 的特点是炎症,在活跃的疾病区域观察到基因表达变化.
- 了解炎症和非炎症组织中的分子活性对于UC管理至关重要.
研究的目的:
- 研究UC患者内镜炎症和非炎症区域的炎症和组织重塑的分子标志物.
- 为了比较UC患者和健康对照者之间的这些标记,以及具有和没有粘膜愈合的患者之间的这些标记.
主要方法:
- 预计将招募47名UC患者和20名对照组.
- 从UC患者的炎症和非炎症组织的结肠镜活检.
- 测量关键基因的信使RNA (mRNA) 表达,包括TGF-β,IL-1β,IL-6,E-cadherin,OLFM4,LGR5,维丁,FSP1和α-SMA.
主要成果:
- 结核病患者的TGF-β,IL-1β,OLFM4,FSP1,维门丁和α-SMA的mRNA表达显著更高,E-cadherin的表达也比控制组在炎症和非炎症区域的表达更低.
- 与MH患者相比,非粘膜愈合 (非MH) 的UC患者在炎症区域的TGF-β,FSP1,维丁和α-SMA的表达显著更高.
- 与MH患者相比,非MH患者在非炎症区域中也表现出较高的TGF-β,IL-1β,IL-6,维门丁和α-SMA的表达.
结论:
- 在UC的内镜活动与炎症和组织重塑有关,在炎症和非炎症区域.
- 无炎症区域的这些分子变化反映了炎症区域的变化,表明这是一个全身的过程.
- 这些发现突出了UC治疗干预的潜在分子标,特别是在没有治愈的病例中.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
08:52Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
4.4K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Inflammatory Bowel Disease I: Ulcerative Colitis
184
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
184
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
